Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 87 entries
View as:

Psyco Quality of Life and Procreation BRCA1/2

Phase: N/A Priority: Normal
NCT ID: NCT05857670 Org: User:
Start: 05/31/22 End: 12/31/24 Due: 12/31/25

Low Intensity Shock Wave Therapy in the Rehabilitation Treatment of Erectile Dysfunction After Robotic Radical Prostatectomy.

Phase: N/A Priority: Normal
NCT ID: NCT06442020 Org: User:
Start: 09/15/23 End: 09/15/26 Due: 09/15/27

Inhibition of Che-1/AATF as a New Tool in Multiple Myeloma Treatment

Phase: N/A Priority: Normal
NCT ID: NCT05858203 Org: User:
Start: 12/22/20 End: 12/31/25 Due: 12/31/26

Efficacy of the Association of Fractionated SRS and Subsequent Surgery in Patients With Brain Metastases

Phase: N/A Priority: Normal
NCT ID: NCT06992973 Org: User:
Start: 09/26/24 End: 09/26/29 Due: 09/26/30

Urinary Microbiome Differences in Bladder Cancer, Benign Urinary Diseases and Healthy Counterparts in Adult Male Population

Phase: N/A Priority: Normal
NCT ID: NCT06992986 Org: User:
Start: 02/06/24 End: 07/06/25 Due: 07/06/26

Prospective Validation of a DNA Damage Repair-Hippo Pathway Signature in Patients With Advanced Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06204523 Org: User:
Start: 10/26/18 End: 08/30/24 Due: 08/30/25

Clinical Trial of Telenursing for Monitoring Supportive Care Needs in Patients With Lung Cancer and Melanoma Candidates for the First Prescription of Targeted Therapies

Phase: N/A Priority: Normal
NCT ID: NCT06254196 Org: User:
Start: 03/01/24 End: 09/01/25 Due: 09/01/26

Evaluating the Role of Both PSMA and 64Cu-PET/CT Total Body in Patients With Locally Relapsed Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04703543 Org: User:
Start: 06/22/17 End: 06/09/20 Due: 06/09/21

Study of the Risk of Pharyngocutaneous Fistula in a Population of Patients Undergoing Total Laryngectomy and Creation of a Score for Pre-operative Risk Stratification.

Phase: N/A Priority: Normal
NCT ID: NCT06308016 Org: User:
Start: 12/01/23 End: 12/01/24 Due: 12/01/25

Analysis of HPV and Biomarkers Present in the Biological Fluids of Patients Suffering From Head and Neck Cancer as a Non-invasive Strategy for Detecting Recurrence

Phase: N/A Priority: Normal
NCT ID: NCT06224166 Org: User:
Start: 01/17/23 End: 01/17/25 Due: 01/17/26

Valveless Trocar Versus Standard Trocar in Robot-assisted Complex Partial Nephrectomy

Phase: N/A Priority: Normal
NCT ID: NCT05732857 Org: User:
Start: 02/08/23 End: 01/30/25 Due: 01/30/26

Recovery From Anesthesia After Robotic Assisted Radical Cystectomy

Phase: N/A Priority: Normal
NCT ID: NCT03144453 Org: User:
Start: 05/02/17 End: 12/31/19 Due: 12/31/20

Three-pronged Centralized Molecular Analysis to Optimize Detection of NTRK1,2,3 Fusions in Thyroid Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05796258 Org: User:
Start: 07/26/21 End: 12/04/24 Due: 12/04/25

Early Salvage Stereotactic Radiotherapy for Biochemical Failure After RP

Phase: N/A Priority: Normal
NCT ID: NCT05667636 Org: User:
Start: 09/27/22 End: 09/27/24 Due: 09/27/25

Goal Directed Therapy (GDT) in Cytoreductive Surgery (CRS) and Hyperthermic Intra Peritoneal Chemotherapy (Hipec)

Phase: N/A Priority: Normal
NCT ID: NCT01882920 Org: User:
Start: 06/30/10 End: 09/30/12 Due: 09/30/13

Determination of Predictive Genetic Markers of Toxicity After Hypofractionated Radiotherapy in Breast Cancer Patients Post-Conservative Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01316328 Org: User:
Start: 05/31/10 End: 12/31/10 Due: 12/31/11

A Study, Comparing a Dose-Titration Regimen of Fulvestrant With the Approved Dosing Regimen in Postmenopausal Patients With Hormone-Responsive Advanced Breast Cancer (ABC)

Phase: N/A Priority: Normal
NCT ID: NCT00927511 Org: User:
Start: 10/31/08 End: 04/30/12 Due: 04/30/13

Percutaneous Laparoscopy for Ovarian Tissue Cryopreservation.

Phase: N/A Priority: Normal
NCT ID: NCT05134090 Org: User:
Start: 05/10/21 End: 08/01/21 Due: 08/01/22

Association of Thoraco-mediastinal Radiotherapy With Maintenance Immunotherapy Treatment With Atezolizumab

Phase: N/A Priority: Normal
NCT ID: NCT06771518 Org: User:
Start: 12/15/21 End: 12/15/26 Due: 12/15/27

Sevoflurane Protective Effect on Ischemia-reperfusion Injury. Multicenter, Randomized Controlled Trial

Phase: N/A Priority: Normal
NCT ID: NCT01905501 Org: User:
Start: 02/28/13 End: 02/28/15 Due: 02/28/16

MALE Mamm Organoids

Phase: N/A Priority: Normal
NCT ID: NCT06786663 Org: User:
Start: 04/19/24 End: 04/19/27 Due: 04/19/28

Time Efficiency of Intracorporeal Orthotopic Diversion With Robotic Staplers After Robot Assisted Radical Cystectomy

Phase: N/A Priority: Normal
NCT ID: NCT02665156 Org: User:
Start: 01/31/16 End: 09/30/18 Due: 09/30/19

Single-cell RNAseq Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05807516 Org: User:
Start: 12/14/21 End: 12/31/24 Due: 12/31/25

Generation of Organoids of Neuroendocrine Neoplasms of the Gastro-Entero-Pancreatic Tract Obtained From Patients Undergoing Surgery

Phase: N/A Priority: Normal
NCT ID: NCT06519500 Org: User:
Start: 03/03/23 End: 11/03/26 Due: 11/03/27

Validation Study of a Serum-miRNA Signature in Glioma Patients.

Phase: N/A Priority: Normal
NCT ID: NCT06178692 Org: User:
Start: 05/10/20 End: 05/10/24 Due: 05/10/25